About this episode
National Economic Council Director Kevin Hassett discusses America’s economic trajectory, including the jobs market and productivity, inflation, and President Trump’s pick for new Fed chair, Kevin Warsh. Direct-to-consumer telehealth Hims & Hers made waves last month when it announced a cheaper, compounded obesity pill similar to Wegovy. Now, after the FDA warned against compounded GLP-1s, Hims & Hers is backing off. Former FDA Commissioner Dr. Scott Gottlieb discusses competition in obesity drugs, Novo Nordisk’s lawsuit against Hims & Hers, and the importance of vaccines. Plus, the pharma and AI ads at Super Bowl LX, Japanese Prime Minister Sanae Takaichi secured a supermajority in a snap election, and CNBC’s Emily Wilkins reports on the legislative efforts to address the U.S. housing affordability crisis.
Emily Wilkins - 10:09
Kevin Hassett - 19:21
Dr. Scott Gottlieb - 30:10
In this episode:
Emily Wilkins, @emrwilkins
Becky Quick, @BeckyQuick
Joe Kernen, @JoeSquawk
Andrew Ross Sorkin, @andrewrsorkin
Cameron Costa, @CameronCostaNY
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Squawk Pod
25 Years Later 9/11/26
Squawk Pod
AI Alarms, Canada’s Opposition, The GOP Convention 9/10/26
Squawk Pod
Microsoft’s Brad Smith & Utah Gov. Cox: AI, Teaching, & Peace 9/9/26
Squawk Pod
GLPs & Fraud with Dr. Oz & Kevin O’Leary’s $11m Baseball Card 9/8/26
Squawk Pod